¡¡
¡¡
¡¡
HOME > ÇÐȸ°£Ç๰ > ¿ë¾î»çÀü
Á¦¸ñ A STUDY ON RELAPSE IN FOLLOW-UP CASES AFTER COMPLETION OF MULTIDRUG THERAPY
ÀúÀÚ Sung Jun Choi ¼Ò¼Ó Institute for Leprosy Research, KLCA
³âµµ 1990 ±Ç 23
È£ 1 ¹øÈ£
½ÃÀÛÆäÀÌÁö 55 ³¡ÆäÀÌÁö 59
÷ºÎ
¿ä¾à This study is a follow-up of 55 leprosy patients on MDT who were released from
treatment. Patients who had been released from treatment were re-examined clinically
and bacteriologically every 6 months for 6 to 78 months (average duration 2 years and
11 months) and following results were obtained.
1. There was no relapse case in 27 MB cases.
2. There were 2 patients who had relapsed (7%) in 28 PB cases, and relapses occurred
10 months and 20 months after completion of MDT subsequently.
3. There were 3 BT cases which were positive in skin smear (BI 1+) at the initiation
of MDT in 28 PB cases. Of those 3 cases, 2 cases relapsed. So it would be better to
classify BI 1+ cases as multibacillary type as WHO Experty committee on Leprosy
recommended.
4. One of the 2 relapsed BT cases had multiple macular lesions and multiple
involvement of peripheral nerves at the initiation of MDT. So in this variety of BT
leprosy, classification should therefore be undertaken only after careful consideration of
all clinical features and careful follow-up should be done for occurrence of reversal
reactions and/or relapse.
5. Durations of MDT in 2 relapsed case were 26 months and 42 months. So
implementation of MDT for 6 months in PB seems to be not enough.
³»¿ë
 
¡¡
¡¡
¡¡